U.S. Healthcare Services Stock News

Investors are treading carefully with ZIM Integrated Shipping Services (NYSE:ZIM) this week, as the company’s upcoming earnings report has prompted a wave of lowered earnings expectations and an unusual increase in put option activity. See our latest analysis for ZIM Integrated Shipping Services. While ZIM Integrated Shipping Services has struggled in 2025, with a year-to-date share price return of -31.3%, the past month tells a different story as buyers have pushed the share price up more...

The Abu Dhabi Investment Office recently announced a collaboration with DiDi Autonomous Driving, a subsidiary of DiDi Global, to accelerate autonomous transport technologies in the Middle East, with DiDi joining Abu Dhabi’s Smart and Autonomous Vehicle Industries (SAVI) cluster. This marks DiDi Autonomous Driving’s first step into the Middle East, with a focus on technology innovation, AI talent development, and ecosystem building for smart mobility in the region. We'll explore how DiDi’s...

Modine Manufacturing (MOD) saw a rise in attention as CEO Neil D. Brinker and company leaders participated in the Crypto & AI/Energy Infrastructure Conference 2025. Investors often use these industry gatherings to gauge the company’s direction and priorities. See our latest analysis for Modine Manufacturing. After grabbing headlines with its high-profile industry conference appearance and a board retirement announcement, Modine Manufacturing’s share price has pulled back 14.2% over the past...

Cipher Mining (CIFR) shares have drawn attention following recent trading activity that stands out against the company's volatile performance over the past month. Investors seem to be re-evaluating the stock as sentiment shifts within the broader cryptocurrency sector. See our latest analysis for Cipher Mining. While Cipher Mining's past week saw a sharp pullback in share price returns, the bigger story is the huge momentum built up over the past year, with a 197% year-to-date share price...

Ameren Corporation reported strong third-quarter and nine-month financial results, with revenue rising to US$2.70 billion and US$7.02 billion, respectively, and increased its 2025 GAAP EPS guidance while providing initial 2026 outlook. The sharp rise in both revenue and net income, alongside upgraded guidance, signals management’s confidence in ongoing growth and operational momentum. We’ll explore how Ameren’s upward revision of earnings guidance shapes the company’s forward-looking...

Ever wondered if Altria Group is offering real value right now, or if the ship has already sailed? Let’s dig into the numbers and recent movements to find out what is really driving the stock. Altria shares have seen a modest 0.3% lift over the last week, but are still up 10.8% year-to-date and 11.6% over the past year, despite a recent 10.5% dip in just the past month. Recently, Altria has been making headlines with its efforts to innovate beyond traditional tobacco, particularly with moves...

American International Group (AIG) announced an unexpected change in its executive leadership, stating that John Neal will not assume the role of President as planned, citing personal circumstances. The board and CEO are now reassessing their approach. See our latest analysis for American International Group. While AIG’s abrupt shift in leadership has certainly turned heads, the share price has mostly held its ground, up 6.5% year-to-date, suggesting investors are weighing steady fundamentals...

CDW (CDW) just reported its third quarter financial results, capturing investor focus with updates on sales and profits. The company also raised its quarterly dividend slightly and revealed recent share buyback activity. See our latest analysis for CDW. CDW shares are hovering near $145 after a steady stream of company updates, including a dividend hike and continued share repurchases. While the stock has lost ground this year with a year-to-date share price return of -14.7% and a one-year...

Natural Resource Partners (NRP) shares have held relatively stable over the past month, moving just slightly despite broader volatility in energy markets. Investors may be weighing the company’s latest financials and considering the long-term return profile. See our latest analysis for Natural Resource Partners. Despite a quiet month for the share price, Natural Resource Partners has built significant wealth for longer-term holders. The company posted a 2.31% total shareholder return over the...

JBS (NYSE:JBS) shares edged higher on light trading volume, with the stock gaining just under 1% at the close. Investors appear focused on recent price action and broader sector shifts as they consider potential next steps for the company. See our latest analysis for JBS. After slipping earlier this quarter, JBS’s share price has stabilized. The stock gained 2.2% over the past week and has shown a modest 1.8% 30-day share price return. While it has not fully recovered from its recent 90-day...

Mattel (MAT) recently reported its third-quarter results, missing expectations on both revenue and profit as tariff challenges weighed on North American sales. Investor attention quickly shifted to the company’s outlook and management’s response. See our latest analysis for Mattel. Despite the dip after earnings, Mattel’s 1-month share price return of 5.05% and 90-day climb of 7.74% suggest momentum has not faded just yet. While short-term swings reflect shifting risk perceptions, Mattel’s...

In the past week, Oscar Health announced the launch of new affordable, technology-enhanced health plans with expanded virtual care and AI-driven services in Southern Florida, while also reporting a significant third-quarter net loss and reaffirming its full-year revenue guidance. A crucial insight is that investor concerns were heightened by both political proposals to redirect federal healthcare funding away from insurers and the company's ongoing profitability challenges, despite its...

Trevi Therapeutics recently announced the advancement of its chronic cough clinical program, reporting reduced net losses for the third quarter and a strong cash position expected to support operations into 2028. An additional highlight is the successful completion of a large fundraising effort and the company’s growing momentum in pursuing late-stage trials for chronic cough therapies. We'll explore how Trevi’s robust financial position and progress toward Phase 3 trials for chronic cough...

Novo Nordisk (NYSE:NVO) stock has seen mixed performance in recent weeks, with shares down about 11% over the past month. Investors are watching as broader biotech sentiment and sector trends influence the company’s valuation. See our latest analysis for Novo Nordisk. Novo Nordisk’s latest 30-day share price return of minus 11.24% comes after a year-to-date decline of nearly 45%, with momentum clearly fading despite some previous bright spots. The one-year total shareholder return stands at...

Plains All American Pipeline recently completed two fixed-income offerings totaling over US$750 million, issuing new senior unsecured notes with maturities in 2031 and 2036, and reported its third-quarter 2025 earnings showing net income of US$441 million, up from US$220 million a year earlier. This combination of improved profitability and successful capital raising highlights the company's ability to maintain financial flexibility while executing on its operational and funding...

Recently, Huron Consulting Group announced the acquisition of AXIOM Systems' payor consulting services division to bolster its healthcare sector capabilities. This move is seen as expanding Huron’s access to healthcare payor clients and driving further growth in performance improvement projects. We'll explore how this targeted acquisition may shape Huron’s investment narrative amid ongoing sector expansion and analyst optimism. Trump has pledged to "unleash" American oil and gas and these 22...

Wondering whether UMB Financial is a hidden gem or already fairly priced? If you care about value, you’re in the right place to unpack where the stock stands right now. UMB Financial’s share price has dipped by 0.5% over the past week and slipped 0.4% over the past month, bringing its year-to-date return to -3.0%. Despite this, the stock has delivered a notable 34.8% gain over three years and an impressive 72.4% return over five years. Recent headlines surrounding UMB Financial have...

Zimmer Biomet Holdings (ZBH) just received FDA 510(k) clearance for its ROSA Knee with OptimiZe. This is a major step forward in robotic-assisted knee replacement technology. This development could shape both patient outcomes and the company's competitive standing in orthopedics. See our latest analysis for Zimmer Biomet Holdings. Despite upbeat product news and solid sales growth in recent quarters, Zimmer Biomet’s 1-year total shareholder return of -19.35% and five-year total return of...

Phreesia (PHR) just got a boost as BMO Capital initiated coverage with an 'Outperform' rating. This comes as other analysts continue to show optimism toward the company’s business and valuation prospects. See our latest analysis for Phreesia. After a stretch of analyst optimism, Phreesia’s share price has retreated, down 25% over the last 90 days. Yet patient investors have still enjoyed a strong 20.7% total shareholder return over the past year. While momentum has cooled recently, that...

Affiliated Managers Group reported a strong third-quarter 2025 performance, posting US$528 million in sales and US$212.4 million in net income, while affirming a US$0.01 per share dividend and completing a sizeable share repurchase program. The sharp increase in net income and earnings per share, along with ongoing capital returns to shareholders, highlights improved profitability and confidence in the company’s financial position. We'll explore how the surge in quarterly earnings and active...

Ever wondered if Blackstone is a hidden gem or overhyped in today’s market? Let’s break down what recent trends can tell us about its value right now. Despite a 68.9% gain over the past three years and total returns of 186.6% over five years, Blackstone shares have dropped 3.1% in the last week and sit 19.6% below their price from a year ago. Analysts and investors have been reacting to headlines around shifting interest rates, the firm’s activity in alternative assets, and broader market...

Structure Therapeutics (GPCR) released its third quarter earnings, reporting a net loss of $65.71 million compared to $33.98 million a year ago. Loss per share nearly doubled and reached $1.11 this quarter. See our latest analysis for Structure Therapeutics. Despite reporting a substantially wider net loss this quarter, Structure Therapeutics’ share price has surged with momentum building. The 30-day share price return is an impressive 34.5%, and its 1-year total shareholder return stands at...

Earlier this month, The Brink's Company reported higher third quarter sales and earnings alongside the completion of a significant tranche of its share buyback program, while also confirming its intention to pursue acquisitions, particularly within growing AMS and DRS markets. Brink's renewed emphasis on capital allocation, through both aggressive share repurchases and targeted M&A, highlights its dual focus on shareholder returns and business expansion in evolving segments. We'll explore...

Wondering whether Adobe’s current share price represents a true bargain or just another blip in the market? You’re not alone. Let's dig in and see what’s really happening beneath the surface. Adobe’s stock price has slipped 0.6% over the past month and is down 24.9% year-to-date, signaling shifting investor sentiment and raising fresh questions about the company’s potential future returns. Some of this volatility has been fueled by major industry headlines and shifts in the competitive...